Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia.
Sanchez-Pernaute O, Romero-Bueno FI, Selva-O'Callaghan A. Sanchez-Pernaute O, et al. Reumatol Clin (Engl Ed). 2021 Nov;17(9):556-557. doi: 10.1016/j.reumae.2020.03.005. Reumatol Clin (Engl Ed). 2021. PMID: 34756322 Free PMC article. No abstract available.
Influence of MUC5B gene on antisynthetase syndrome.
López-Mejías R, Remuzgo-Martínez S, Genre F, Pulito-Cueto V, Rozas SMF, Llorca J, Fernández DI, Cuesta VMM, Ortego-Centeno N, Gómez NP, Mera-Varela A, Martínez-Barrio J, López-Longo FJ, Mijares V, Lera-Gómez L, Usetti MP, Laporta R, Pérez V, Gafas AP, González MAA, Calvo-Alén J, Romero-Bueno F, Sanchez-Pernaute O, Nuno L, Bonilla G, Balsa A, Hernández-González F, Grafia I, Prieto-González S, Narvaez J, Trallero-Araguas E, Selva-O'Callaghan A, Gualillo O, Castañeda S, Cavagna L, Cifrian JM, González-Gay MA. López-Mejías R, et al. Sci Rep. 2020 Jan 29;10(1):1415. doi: 10.1038/s41598-020-58400-0. Sci Rep. 2020. PMID: 31996780 Free PMC article.
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia.
Sanchez-Pernaute O, Romero-Bueno FI, Selva-O'Callaghan A. Sanchez-Pernaute O, et al. Reumatol Clin. 2021 Nov;17(9):555-557. doi: 10.1016/j.reuma.2020.03.001. Epub 2020 Apr 16. Reumatol Clin. 2021. PMID: 32354685 Free PMC article. No abstract available.
Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease.
Romero-Bueno F, Diaz Del Campo P, Trallero-Araguás E, Ruiz-Rodríguez JC, Castellvi I, Rodriguez-Nieto MJ, Martínez-Becerra MJ, Sanchez-Pernaute O, Pinal-Fernandez I, Solanich X, Gono T, Gonzalez-Gay MA, Plana MN, Selva-O'Callaghan A; MEDRA5 (Spanish MDA5 Register) group (listed contributors at the end of the article). Romero-Bueno F, et al. Semin Arthritis Rheum. 2020 Aug;50(4):776-790. doi: 10.1016/j.semarthrit.2020.03.007. Epub 2020 Jun 1. Semin Arthritis Rheum. 2020. PMID: 32534273
HLA association with the susceptibility to anti-synthetase syndrome.
Remuzgo-Martínez S, Atienza-Mateo B, Ocejo-Vinyals JG, Pulito-Cueto V, Prieto-Peña D, Genre F, Marquez A, Llorca J, Mora Cuesta VM, Fernández DI, Riesco L, Ortego-Centeno N, Gómez NP, Mera A, Martínez-Barrio J, López-Longo FJ, Lera-Gómez L, Moriano C, Díez E, Tomero E, Calvo-Alén J, Romero-Bueno F, Sanchez-Pernaute O, Nuño L, Bonilla G, Grafia I, Prieto-González S, Narvaez J, Trallero-Araguas E, Selva-O'Callaghan A, Gualillo O, Martín J, Cavagna L, Castañeda S, Cifrian JM, Renzoni EA, López-Mejías R, González-Gay MA. Remuzgo-Martínez S, et al. Joint Bone Spine. 2021 May;88(3):105115. doi: 10.1016/j.jbspin.2020.105115. Epub 2020 Dec 7. Joint Bone Spine. 2021. PMID: 33301929 Free article.
Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease.
Selva-O'Callaghan A, Romero-Bueno F, Trallero-Araguás E, Gil-Vila A, Ruiz-Rodríguez JC, Sánchez-Pernaute O, Pinal-Fernández I. Selva-O'Callaghan A, et al. Curr Treatm Opt Rheumatol. 2021;7(4):319-333. doi: 10.1007/s40674-021-00186-x. Epub 2021 Sep 28. Curr Treatm Opt Rheumatol. 2021. PMID: 34603940 Free PMC article. Review.
Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome.
Remuzgo-Martínez S, Atienza-Mateo B, Ocejo-Vinyals JG, Genre F, Pulito-Cueto V, Mora-Cuesta VM, Iturbe-Fernández D, Lera-Gómez L, Pérez-Fernández R, Prieto-Peña D, Irure J, Romero-Bueno F, Sanchez-Pernaute O, Alonso-Moralejo R, Nuño L, Bonilla G, Vicente-Rabaneda EF, Grafia I, Prieto-González S, Narvaez J, Trallero-Araguas E, Selva-O'Callaghan A; Spanish Biomarkers of Antisynthetase Syndrome Consortium; Spanish Biomarkers of Interstitial Lung Disease Consortium; Gualillo O, Cavagna L, Cifrián JM, Renzoni EA, Castañeda S, López-Mejías R, González-Gay MA. Remuzgo-Martínez S, et al. Sci Rep. 2021 Nov 19;11(1):22574. doi: 10.1038/s41598-021-01992-y. Sci Rep. 2021. PMID: 34799647 Free PMC article.
[Erdheim-Chester disease: study of 12 cases].
Juanós Iborra M, Selva-O'Callaghan A, Solanich Moreno J, Vidaller-Palacin A, Martí S, Grau Junyent JM, Vilardell Tarrés M; Grupo para estudio de la Enfermedad de Erdheim-Chester. Juanós Iborra M, et al. Med Clin (Barc). 2012 Oct 13;139(9):398-403. doi: 10.1016/j.medcli.2012.05.001. Epub 2012 Jul 12. Med Clin (Barc). 2012. PMID: 22795496 Spanish.
[Anti-synthetase syndrome].
Labirua-Iturburu A, Trallero Araguás E, Selva O'Callaghan A. Labirua-Iturburu A, et al. Med Clin (Barc). 2011 Jun 11;137(2):77-83. doi: 10.1016/j.medcli.2011.02.026. Epub 2011 May 4. Med Clin (Barc). 2011. PMID: 21543090 Spanish. No abstract available.
211 results